Jiangsu Vcare

Nanjing, China · Founded 2010 · Privately Held (backing)

Developer of innovative drugs designed to treat cardiovascular and cerebrovascular, tumors, endocrine, and other areas of chronic diseases. Jiangsu Vcare is based in Nanjing, China and was founded in 2010. Its last reported valuation was $162 million in Feb 2021. It has raised $225 million.

Last reported valuation
$162.4M
Oct 2026
Priced at
—
Total raised
$225.4M
Last round
—
What is Jiangsu Vcare worth?
$162.4Mlast reported valuation · Oct 2026

Jiangsu Vcare's last reported valuation, Feb 2021. Nothing priced has surfaced since.

Free account
More of Jiangsu Vcare with a free account
  • ·The complete investor list: 17 names
  • ·Watch Jiangsu Vcare: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Jiangsu Vcare funding history

No rounds on record

No funding rounds for Jiangsu Vcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Jiangsu Vcare valuation

Jiangsu Vcare's last reported valuation was $162 million in Feb 2021. No priced round, secondary trade or fund mark has surfaced since.

How Jiangsu Vcare's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Jiangsu Vcare, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Jiangsu Vcare

What is Jiangsu Vcare worth?
Jiangsu Vcare is valued at $162.4M as of Oct 2026. Jiangsu Vcare's last reported valuation, Feb 2021. Nothing priced has surfaced since.
How much has Jiangsu Vcare raised?
Jiangsu Vcare has raised $225.4M in total funding across its recorded rounds.